Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombination cytohesin antagonism polypeptide TAT-Sec 7 and preparation method thereof

A tat-sec7, antagonistic technology, applied in the fields of genetic engineering and biopharmaceuticals, can solve problems such as difficult treatment methods

Inactive Publication Date: 2015-11-18
JILIN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment methods for malignant tumors mainly include surgical treatment, radiotherapy and chemotherapy, etc., but the metastasis of cancer cells has added great difficulties to these three treatment methods. Tumor metastasis has become the main cause of death of cancer patients. Drugs that inhibit tumor metastasis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombination cytohesin antagonism polypeptide TAT-Sec 7 and preparation method thereof
  • Recombination cytohesin antagonism polypeptide TAT-Sec 7 and preparation method thereof
  • Recombination cytohesin antagonism polypeptide TAT-Sec 7 and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Design of recombinant Cytohesin antagonistic polypeptide fusion gene.

[0028] According to the amino acid sequence of the ARNO of the Cytohesin family, find Sec7 reported in the literature, optimize the nucleotide sequence according to the preferred codons of E. coli, and then add a transmembrane peptide (TAT) sequence at its 5' end, and add a 6His tag at its 3' end sequence. sequence design as figure 1 shown.

Embodiment 2

[0030] PCR synthesis of recombinant Cytohesin antagonistic polypeptide fusion gene and construction of pET-20b-recombinant Cytohesin antagonistic polypeptide expression vector.

[0031] In order to obtain the sequence of the TAT-Sec7 gene sequence, design primers as shown in Table 1, use P1 and P2 as primers (see Table 1 for primer sequences), and synthesize the TAT-Sec7 sequence by PCR method.

[0032]

[0033] Reaction program: pre-denaturation at 98°C for 5min; denaturation at 98°C for 10min; annealing at 55°C for 15s; extension at 72°C for 1min, 30 cycles, and finally extension at 72°C for 5min. After no non-specific bands were detected by 1% agarose gel electrophoresis, the DNA fragment of the product was purified and recovered with a DNA gel recovery kit, and then the fragment was double-digested with NdeI and XhoI, and then digested with the same two enzymes. The pET-20b plasmid was subjected to enzyme reaction to obtain the pET-20b-TAT-Sec7 plasmid. The result is a...

Embodiment 3

[0037] Recombinant Cytohesin antagonizes the acquisition of polypeptide fusion protein.

[0038] 1. Induced expression

[0039]Shake culture pET-TAT-Sec7-his transformed Escherichia coli BL21(DE3) host cells at 37°C for 16 hours, then transfer to fresh LB medium at a ratio of 5%. Under induction for 3 hours, ultrasonic (200w, ultrasonic 5s, interval 5s, cycle 180 times) to break the bacteria, the recombinant protein can account for more than 70% of the soluble bacterial protein, the results are as follows image 3 shown. Among them: a is the whole bacteria before induction; b, c, d are the expression of TAT-Sec7 after induction.

[0040] 2. Purification of Recombinant Proteins

[0041] Load the sample onto the Ni-NTA affinity chromatography column, equilibrate the Ni-NTA chromatography column with buffer solution 50mmol / LTris-HCl, pH8.0, 0.5mol / LNaCl, 10mmol / L imidazole, and drain the lysate to the equilibrium well In the column, wash with buffer solution 50mmol / L Tris-HCl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The invention relates to recombination cytohesin antagonism polypeptide TAT-Sec 7 and a preparation method thereof. According to the recombination cytohesin antagonism polypeptide provided by the invention, a gene sequence of a cell-penetrating peptide is added to 5' terminal of a Sec 7 fragment of the cytohesin gene described in a code, so that a fused gene is formed; the fused gene is cloned to a prokaryotic expression vector and the induced expression is carried out on escherichia coli cells, and then the separation and purification of a protein is carried out to obtain a fusion protein. The recombination cytohesin antagonism polypeptide TAT-Sec 7 has the combination of ARNO / cytohesin and ARF6 or catalysis, so that the activating characteristic of ARF 6 is inhabited. The recombination polypeptide fusion protein can be used for preparing a medicine for treating tumor metastasis.

Description

technical field [0001] The invention belongs to the fields of genetic engineering and biopharmaceuticals, and specifically relates to the preparation and application of a recombinant Cytohesin antagonistic polypeptide. Background technique [0002] Tumor is a new organism formed by the abnormal proliferation of cells in the body, and it often appears as a local abnormal tissue mass in the body. Tumors are divided into benign tumors and malignant tumors, and the so-called cancer refers to malignant tumors. Malignant tumors, as one of the largest public health problems in the world, have greatly endangered human health and will become the number one killer of human beings in the new century. The treatment methods for malignant tumors mainly include surgical treatment, radiotherapy and chemotherapy, etc., but the metastasis of cancer cells has added great difficulties to these three treatment methods. Tumor metastasis has become the main cause of death of cancer patients. Dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/00C12N15/70C12P21/02
CPCC07K14/00
Inventor 肖业臣彭晓凡孙艳
Owner JILIN UNIV